 |
| june
10, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Anodyne Nanotech: Drives Major Advancement
in the Treatment of Sarcopenia With Novel
Muscle-Preserving Therapy More
- Beacon Therapeutics: Strengthens
Leadership Team With the Appointment of Dr.
Daniel Chung as Chief Medical Officer More
- BostonGene: Multiomic AI Platform Uncovers
Therapeutic Targets in Invasive Lobular
Carcinoma, Wins GRASP Advocate Choice Award at
ASCO 2025 More
- CervoMed: New Hire to Support
Neflamapimod Development and
Commercialization More
- Cristcot: Appoints Richard Kim as Chief
Commercial Officer More
- Emulate: Launches AVA Emulation System to
Accelerate Drug Development With
First-of-its-Kind High-Throughput Organ-Chip
Platform More
More*
- Innoviva Specialty Therapeutics: Receives
FDA New Drug Application Acceptance for
Zoliflodacin, a First-in-Class Oral Antibiotic
for Uncomplicated Gonorrhea in Adults More
- Microbot Medical: Continues to Strengthen
Commercial Capabilities in Preparation for the
anticipated Q3 2025 Launch of Its LIBERTY
Endovascular Robotic System More
- Monte Rosa Therapeutics: FDA Clearance of
IND Application for MRT-8102, a NEK7-Directed
Molecular Glue Degrader for the Treatment of
Multiple Inflammatory Diseases More
- OPKO Health: ModeX Therapeutics Announces
Formation of Scientific Advisory Board With
Leaders at the Forefront of Immunology and
Oncology Drug Development More
- Phare Bio and MIT: Named to Fast Company’s
2025 World Changing Ideas List More
- X4 Pharmaceuticals: Granted Fast Track
Designation for Mavorixafor for the Treatment
of Chronic Neutropenia by U.S. FDA More
|
|
 |
 |
Strategic
CFO Services for Scaling Biotech
Startups
Explore how biotech startups can
leverage fractional CFO services
to scale efficiently |
|
Learn More
→ |
|
|
|
- Activist Investor Demands Keros
‘Aggressively’ Cut Costs Just Weeks After
Layoffs More
- Antares Therapeutics: Launches With $177
Million to Develop First-in-Class Precision
Medicines for Cancer and Other Serious
Diseases More
More*
- Elevation Oncology: Enters Into Agreement
to Be Acquired by Concentra Biosciences for
$0.36 in Cash per Share Plus a Contingent
Value Right More
More
More
More*
- Largest U.S. Life Sciences Hub Fights for a
Piece of Multibillion-Dollar Biomanufacturing
Pie More*
- National Resilience, Startup Hoping to
Reinvent Drug Manufacturing, to 'Wind Down’'
Many of Its Facilities More*
More*
- Phare Bio: Selected to Participate in the
Google.org Accelerator: Generative AI to
Advance Open-Access Antibiotic Discovery
Platform More
|
|
|
|
- AI Biotech nference Claims Ex-Partners
'Stole' Billion-Dollar Asthma Drug in Lawsuit
More*
- Big4Bio: Launches 'AMPLIFY' to Supercharge
Life Sciences Visibility More
- CRADL® & Explora BioLabs:
Unified Culture Forms Successful Merger More
- Harvard: Son’s Diabetes Diagnosis Sent
Scientist on Quest for Cure More
- More on Abcuro Hiring Ex-Alexion, Biohaven
Exec to Lead Commercial Team Ahead of Planned
Launch More
- More on George Medicines Opening New Front
in Hypertension Treatment With FDA Nod for
Combo Pill More
- Odyssey Pulls Back From IPO Plans as
Public Markets Remain Frozen More*
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- Feature: The Future of Hiring: How
Fractional Talent is Reshaping the Workplace
More
- ICYMI: Beyond Cautious Optimism: Why a
Hybrid Talent Model is the Future for Life
Sciences & Healthcare More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
